December 15, 2009 (FinancialWire) Nektar Therapeutics (NASDAQ: NKTR) has appointed Dennis Winger to serve on its board of directors. Winger is currently a director of Vertex Pharmaceuticals (NASDAQ: VRTX), Cephalon (NASDAQ: CEPH) and Accuray (NASDAQ: ARAY). He retired in 2008 from Applera Corp., a life sciences company, where he was senior vice president and chief financial officer.
Previously, Winger was senior vice president of finance, administration and chief financial officer at Chiron. Before that, he held various financial executive leadership roles with divisions of The Cooper Cos.
Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and polymer conjugation technology platforms.
Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). Recently issued reports and filings include Bravo Venture Group Inc. (TSX Venture: BVG), Bellway PLC (London Stock Exchange: BWY) (OTC: BLWYF), Chase Corp. (AMEX: CCF), Continental Materials Corp. (AMEX: CUO), Amcon Distributing Company (AMEX: DIT), Eaton Vance Enhanced Equity Income Fund (NYSE: EOI), Majedie Investments PLC (London Stock Exchange: MAJE), Morgan Stanley Income Securities, Inc. (NYSE: ICB), Grainger PLC (London Stock Exchange: GRI) (OTC: GRTGF), Eaton Vance Insured Municipal Bond Fund (AMEX: EIM), PIMCO High Income Fund (NYSE: PHK) and Shaw Communications, Inc. (NYSE: SJR).
FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors by the FirstAlert(tm) Networks FirstAlert(tm) Daily (http://www.financialwire.net/news-alerts/). Recently-presented company financial results calls, earnings calls and/or shareholder meeting webcasts now available include Aastrom Biosciences, Inc. (NASDAQ: ASTM), Methode Electronics, Inc. (NYSE: MEI), White Electronic Designs Corp. (NASDAQ: WEDC), Cantel Medical Corp. (EXCH: CMN), Frequency Electronics Inc. (EXCH: FEIM), Pep Boys-Manny, Moe & Jack (NYSE: PBY) and Xeta Technologies, Inc. (NASDAQ: XETA). Recordings are accessible via the search function at http://infoescrow.net/f/?u=http://www.investorcalendar.com by entering any companys ticker symbol into the search field.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Strader Named Credit Chief Of Iberiabank December 14, 2009 (FinancialWire) Iberiabank Corp. (NASDAQ: IBKC) has appointed H. Gregg Strader as executive vice president and Chief Credit officer. The position of Chief Credit officer was previously... |
Honig Named To Orexigen Therapeutics Board March 3, 2010 (FinancialWire) Biopharmaceutical firm Orexigen Therapeutics, Inc. (NASDAQ: OREX) has appointed Peter K. Honig to its board of directors. Honig has over 20 years of clinical and regulatory... |
LifeCycle Pharma Promotes Dr. William J. Polvino President, CEO December 4, 2009 (FinancialWire) LifeCycle Pharma A/S (Copenhagen: LCP) has promoted Dr. William J.Polvino new president and CEO. Dr. Polvino has most recently served as chief operating officer of LCP.... |
Rangen Named To Global Defense Board December 2, 2009 (FinancialWire) Global Defense Technology & Systems, Inc. (NASDAQ: GTEC ) said that Eric S. Rangen has been appointed to the companys board of directors. Rangen will chair the audit... |
Ellberger Named Chairman Of Celldex Therapeutics September 8, 2009 (FinancialWire) Larry Ellberger has been appointed chairman of Celldex Therapeutics, Inc. (NASDAQ: CLDX) (Current Market Cap: $86.70 Mil.) Ellberger has been an independent member of... |
Dellaquila Named CFO Of Emerson February 3, 2010 (FinancialWire) Emersons (NYSE: EMR) board of directors has elected Frank J. Dellaquila as senior vice president and chief financial officer. He succeeds Walter J. Galvin, vice chairman... |
